![Sample our Engineering & Technology journals, sign in here to start your access, latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5933/TOC-Subject-Sample-2021-Engineering-Tech.jpg"})
Abstract
Ali Khademhosseini is an Associate Professor at Harvard–Massachusetts Institute of Technology IT Division of Health Sciences and Technology, Brigham and Women‘s Hospital and Harvard Medical School (MA, USA) as well as an Associate Faculty at the Wyss Institute for Biologically Inspired Engineering (MA, USA). He is also a Junior Principal Investigator at Japan‘s World Premier International – Advanced Institute for Materials Research at Tohoku University (Sendai, Japan), where he directs a satellite laboratory. He received his PhD in Bioengineering from Massachusetts Institute of Technology (2005), and MASc (2001) and BASc (1999) degrees from the University of Toronto (Toronto, Japan), both in Chemical Engineering. Ali Khademhosseini spoke exclusively to Therapeutic Delivery about intelligent drug-delivery systems – the topic of this special focus issue.
Interview conducted by Thomas Payne, Commissioning Editor.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.